MFDA lifts sale ban on Panadol
The alert added that the authority has informed the importers and sellers of the standards to be followed in the transportation and storage of the drugs.
By
Fathmath Ahmed Shareef
The Maldives Food and Drug Authority (MFDA) has re-approved the use of Panadol in Maldives.
The import, sale and use of Panadol, the most commonly used painkiller in the country, was temporarily banned on 30th of last month. The drug was banned after tests were conducted and suspicious aspects in the drug's packaging were found.
The MFDA said some of the pills had become loose and crushed within the casing. This happens when it is exposed to heat, air, light or moisture that may affect the stability of the formulation or the active ingredient, which can alter the effectiveness and safety of the medicine.
The MFDA issued an alert on Thursday saying it had received the analysis results of laboratory tests conducted on the drug.
According to the reports:
-
Quantitative tests confirmed the efficacy of the drug as per the Panadol brand.
-
The problem noted with the previously discovered faulty drugs was caused by the lack of compliance with the required standards in the handling and storage of the drugs
-
It has been confirmed that the batch where this problem was detected is no longer on the market
"Therefore, it is hereby announced that the sale and use of this drug has been approved as before," the MFDA alert said.
The alert added that the authority has published and informed the importers and sellers of the standards to be followed in the transportation and storage of the drugs to ensure the safety of the drugs to prevent such cases in future.
